What is LabRad Diagnostics?
LabRad Diagnostics specializes in guiding entrepreneurs through the process of establishing laboratory testing businesses. Their core offering focuses on the setup of CLIA mobile phlebotomy laboratories, providing essential steps and requirements for success in the expanding laboratory testing sector. The company targets individuals and entrepreneurs aiming to enter this market, assisting them in navigating the complexities of operational setup.
How much funding has LabRad Diagnostics raised?
LabRad Diagnostics has raised a total of $250K across 2 funding rounds:
Debt
$150K
Debt
$100K
Debt (2020): $150K with participation from PPP
Debt (2021): $100K led by PPP
Key Investors in LabRad Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for LabRad Diagnostics?
The substantial capital infusion, particularly the recent strategic investment, positions LabRad Diagnostics for significant scaling and market expansion. This late-stage funding suggests a focus on solidifying its market presence, potentially through enhanced service offerings, broader geographic reach, or technological advancements in laboratory diagnostics. The company is poised to leverage this financial backing to further its mission of simplifying the entry into the laboratory testing business for new entrepreneurs.
See full LabRad Diagnostics company page
